The healthcare pioneer shares insights on transformative diagnostics where precision medicine meets women’s health innovation ...

Merck Research Laboratories. “This positive opinion is yet another testament to the clinical profile of CAPVAXIVE and brings us a step closer to helping protect adults in the EU against ...

IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the ...

According to Dr. Paula Annunziato of Merck (NSE:PROR) Research Laboratories, this development brings the company closer to protecting adults in the EU against these diseases, which can lead to ...

Co., Inc. (NYSE: MRK) has initiated a pivotal Phase 3 clinical trial, waveLINE-010, to evaluate the efficacy of its investigational drug zilovertamab vedotin in treating patients with previously ...

Merck Research Laboratories. “We are grateful to the dedicated community of patients who participated in these studies and are pleased to offer the option of receiving WINREVAIR through the ...

Merck Research Laboratories. Winrevair is currently approved in 38 countries including the U.S., based on the results from the Phase 3 STELLAR study. The views and opinions expressed herein are ...

Western drugmakers are striking more deals in China to access “bio-better” treatments for diseases from obesity to cancer, ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for belzutifan for the treatment of adult and pediatric patients aged 12 years and ...

On the C-SPAN Networks:.